Insights

Type Clear all

Select all that apply

Topic Clear all

Select all that apply

icons/content-types/white paper white paper

Hybridoma technology is a popular method for antibody discovery, but the conventional approach of using a single inbred mouse strain for immunization fails to generate the diversity and antibody titers needed to maximize the discovery of high-quality...

icons/content-types/white paper white paper

The combination of the PentaMice® platform and single B cell screening with the Berkeley Lights Beacon® Optofluidic system increases speed to market for monoclonal antibody therapeutics.

icons/content-types/white paper white paper

The clinical value of biologics for the treatment of many disease indications has been accompanied by phenomenal sales. By 2026, the global market for biologics is projected to increase to $537 billion. However, getting a promising drug candidate fro...

icons/content-types/article article

February 28 marks the global observance of Rare Disease Day, a day when we participate in raising awareness and generating change for the global population and their families living with rare diseases.

icons/content-types/article article

A conversation with Lee J. Silverberg, Ph.D. Associate Professor of Chemistry, Pennsylvania State University

icons/content-types/fact sheet fact sheet

Partner with Curia for combined expertise, speed and reliability to support the research, development and manufacturing of your mRNA product.

icons/content-types/article article

Peptide-based pharmaceuticals have been growing in popularity in recent years, but synthesizing these complex drugs presents expensive environmental challenges.

icons/content-types/infographic infographic

We offer a robust portfolio of market-leading APIs and world-class capabilities in niche and high-barrier-to-entry technologies.

icons/content-types/article article

For many who are new to drug development, the greatest challenge is not necessarily discovering a blockbuster molecule—it’s finding a team capable of carrying that molecule through the complexities that lie between the research lab and the patien...

icons/content-types/article article

As pandemic conditions persist, the pharma industry continues to respond as rapidly as possible to bring more vaccine options to the global population. But developing one or more effective vaccines was just the first hurdle to clear. The drug industr...

icons/content-types/video webinar

Watch this webinar to learn why indexing is a useful tool to glean additional information from X-ray powder diffraction data. The expert speaker will discuss the applications of indexing, including demonstrating pure crystalline phase identification...

040E93C7-D189-4233-A102-58C0580BE529 publications patents

The following research articles appeared in peer-reviewed scientific journals that described innovations conceived by Curia scientists. In most of these cases, these manuscripts were written by Curia lead authors to communicate independent research...